Aptus Pharma Ltd strategy deck summary

Strategy deck of 7 Feb 2026, summarised by AI from the filing.

Aptus Pharma targets 450+ products and 25+ therapeutic segments under Vision 2026-30, with Mission Bharat zones from March 2027 to March 2029.

Key takeaways

1. Business model Company markets and distributes finished pharmaceutical formulations through a contract manufacturing model and does not own any manufacturing facilities.
2. Vision 2026-30 Company will launch 450+ products and 25+ therapeutic segments under Vision 2026-30.
3. Mission Bharat Mission Bharat zones are scheduled from March 2027 to March 2029, with a Cosmeceuticals Plant in March 2028.
4. Risk Company does not own manufacturing plants; production depends on contract manufacturers and informal arrangements.

Original filing on BSE

Aptus Pharma Ltd earnings call, investor presentation and press release summaries

• Q1 FY27: Results deck (21 Aug 2026)
• Q4 FY26: Results press release (28 Apr 2026)
• Other events: Strategy deck (7 Feb 2026)